Search by Drug Name or NDC

    NDC 70183-0221-07 INPEFA 200 mg/1 Details

    INPEFA 200 mg/1

    INPEFA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lexicon Pharmaceuticals, Inc.. The primary component is SOTAGLIFLOZIN.

    Product Information

    NDC 70183-0221
    Product ID 70183-221_8c3687e7-b8b3-4586-976b-98035bb896ac
    Associated GPIs
    GCN Sequence Number 084849
    GCN Sequence Number Description sotagliflozin TABLET 200 MG ORAL
    HIC3 C4D
    HIC3 Description ANTIHYPERGLYCEMIC-SOD/GLUC COTRANSPORT2(SGLT2) INH
    GCN 54239
    HICL Sequence Number 048976
    HICL Sequence Number Description SOTAGLIFLOZIN
    Brand/Generic Brand
    Proprietary Name INPEFA
    Proprietary Name Suffix n/a
    Non-Proprietary Name sotagliflozin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name SOTAGLIFLOZIN
    Labeler Name Lexicon Pharmaceuticals, Inc.
    Pharmaceutical Class P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA216203
    Listing Certified Through 2024-12-31

    Package

    NDC 70183-0221-07 (70183022107)

    NDC Package Code 70183-221-07
    Billing NDC 70183022107
    Package 1 BLISTER PACK in 1 CARTON (70183-221-07) / 7 TABLET in 1 BLISTER PACK
    Marketing Start Date 2024-01-15
    NDC Exclude Flag N
    Pricing Information N/A